Cost Analysis for Endoscopic Retrograde Cholangiopancreatography (ERCP)
Withdrawn before enrolling · Not applicable
Conditions studied: Biliary Obstruction
In brief
The purpose of the study is to determine if endoscopist notification of accessory cost results in altered resource utilization related to the total cost and number of accessories used in ERCP. This study will be a prospective cost--analysis study. Only chart review of PHI removed records will be used. The only intervention used is that endoscopists will be made aware of the cost of accessories used in the second phase of the study following each ERCP. The investigators are in an era of increased medical cost consciousness. Medical education and post--graduate education incorporates cost savings and appropriate diagnostic test selection based on expense as one aspects of the decision process. This era now focuses on what is best for the patient with the understanding that the cost to the patient and cost to the overall health care system matters. Not only is this apart of postgraduate training but now being implemented as part of Medicare reimbursement to provide low cost and high quality care. Incidence of pancreatic and biliary disease is increasing. ERCP is a vital tool for therapeutic intervention. The costs of these procedures, to both patients and hospitals, have caused some to question the amount of accessories used as well as the poor reimbursement provided by Medicare and insurers. Studies have indicated that hospitals actually lose money with each ERCP used and their use is being limited many times to tertiary care centers.
Key facts
- Study ID
- NCT02127229
- Run by
- University of Oklahoma
- People needed
- 0
- Starts
- 2014-04-01
- Expected to finish
- 2014-09-01
- Last updated by the study team
- 2017-08-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Adult receiving ERCP at Endoscopy diagnostic center.
You may not qualify if…
- No stent removal or replacement procedures. EUS can only be used for intubation of bile duct. No spyglass will added to total cost.
Where it is running
- University of Oklahoma Health Science Center — Oklahoma City, Oklahoma, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.